Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.54 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | APEX1 | P27695 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | PKLR | P30613 | 2/20 | 0.54 |
| ▸ | GALNT2 | Q10471 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.54 |
| ▸ | PLK4 | O00444 | 1/20 | 0.54 |
| ▸ | IKBKB | O14920 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ellagic Acid 4-O-Xylopyranoside SCHEMBL1699333 | 1.00 | CA12 (0.54) | CA12CA9CA1CA7CA13 | |
| SCHEMBL30637413 | 0.89 | RELA (0.58) | CA12CA9CA1CA7CA13 | |
| SCHEMBL1279510 | 0.88 | MAPT (0.54) | CA12CA9CA1CA7CA13 | |
| Eschweilenol C SCHEMBL1699342 | 0.81 | KDM4E (0.54) | CA12CA9CA1CA7CA13 | |
| Eschweilenol C SCHEMBL15359344 | 0.81 | KDM4E (0.54) | CA12CA9CA1CA7CA13 | |
| Ellagic Acid SCHEMBL1279506 | 0.81 | KDM4E (0.64) | CA12CA9CA1CA7CA13 | |
| SCHEMBL1699331 | 0.81 | HSD17B10 (0.52) | CA12CA9CA1CA7CA13 | |
| SCHEMBL29585250 | 0.80 | SOST (0.53) | CA12CA9CA1CA7CA13 | |
| SCHEMBL31290780 | 0.75 | XDH (0.53) | CA12CA9CA1CA7CA13 | |
| SCHEMBL30658623 | 0.73 | RELA (0.60) | CA12CA9CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564550-B2 | Anti-dandruff composition | MANE KANCOR INGREDIENTS PRIVATE LIMITED (IN) | 2026-03-03 | — | — | US | disclosed |
| EP-3744769-B1 | FILM AND PRODUCTION METHOD | INST JOZEF STEFAN (SI) | 2025-11-26 | — | — | EP | disclosed |
| US-20240050351-A1 | Anti-Dandruff Composition | MANE KANCOR INGREDIENTS PRIVATE LTD (IN) | 2024-02-15 | — | — | US | disclosed |
| US-11857661-B2 | Anti-dandruff composition | MANE KANCOR INGREDIENTS PRIVATE LIMITED (IN) | 2024-01-02 | — | — | US | disclosed |
| US-20230372421-A1 | IMMATURE POMEGRANATE EXTRACT FORMULATIONS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2023-11-23 | — | — | US | disclosed |
| EP-4225343-A1 | IMMATURE POMEGRANATE EXTRACT FORMULATIONS | Consiglio Nazionale Delle Ricerche (IT) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022079592-A1 | IMMATURE POMEGRANATE EXTRACT FORMULATIONS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564550-B2 | Anti-dandruff composition | MDH1, IL17A, PPARD | CA12 3879/4885CA9 3349/4885CA1 4553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.